Image de couverture de livre

Distinct 2-phenylimidazo(1,2-a)pyridine derivatives that inhibit breast cancer cell proliferation identified as AHR ligands

X15695 is a 2-phenylimidazo[1,2-a] pyridine derivative previously described as an orally active, selective estrogen receptor (ER) degrader that inhibits the proliferation of ER+ breast cancer cells. Here, we show that X15695 and derivatives are aryl hydrocarbon receptor (AHR) ligands. Knockout of AH...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Koellisch, Katrin (Auteur) , Blattner, Christine (Auteur) , Motta, Stefano (Auteur) , Wesslowski, Janine (Auteur) , Rothley, Melanie (Auteur) , Büchel, Simone (Auteur) , Sirounian, Savannah (Auteur) , Segatto, Ilenia (Auteur) , Weber, Hanna (Auteur) , Müller, Julia (Auteur) , Grimaldi, Marina (Auteur) , Stober, Jutta (Auteur) , Wammetsberger, Zoe (Auteur) , Pan, Mengwu (Auteur) , Houtman, René (Auteur) , Grathwol, Christoph W. (Auteur) , Lin, Lo-Wei (Auteur) , Buluwela, Laki (Auteur) , Kolluri, Siva Kumar (Auteur) , Mytzka, Dominik (Auteur) , Ali, Simak (Auteur) , Jung, Nicole (Auteur) , Balaguer, Patrick (Auteur) , Thaler, Sonja (Auteur) , Belletti, Barbara (Auteur) , Bonati, Laura (Auteur) , Bourguet, William (Auteur) , Bräse, Stefan (Auteur) , Davidson, Gary (Auteur) , Cato, Andrew C. B. (Auteur)
Format: Article (Journal)
Langue:anglais
Publié: June 19, 2026
In: iScience
Year: 2026, Volume: 29, Numéro: 6, Pages: 1-17, e1-e7
ISSN:2589-0042
DOI:10.1016/j.isci.2026.115936
Accès en ligne:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.isci.2026.115936
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2589004226013118
Accéder au texte intégral
Notes sur l'auteur:Katrin Koellisch, Christine Blattner, Stefano Motta, Janine Wesslowski, Melanie Rothley, Simone Büchel, Savannah Sirounian, Ilenia Segatto, Hanna T. Weber, Julia Müller, Marina Grimaldi, Jutta Stober, Zoe Wammetsberger, Mengwu Pan, René Houtman, Christoph W. Grathwol, Lo-Wei Lin, Laki Buluwela, Siva Kumar Kolluri, Dominik Mytzka, Simak Ali, Nicole Jung, Patrick Balaguer, Sonja Thaler, Barbara Belletti, Laura Bonati, William Bourguet, Stefan Bräse, Gary Davidson, and Andrew C.B. Cato
Description
Résumé:X15695 is a 2-phenylimidazo[1,2-a] pyridine derivative previously described as an orally active, selective estrogen receptor (ER) degrader that inhibits the proliferation of ER+ breast cancer cells. Here, we show that X15695 and derivatives are aryl hydrocarbon receptor (AHR) ligands. Knockout of AHR abolishes the anti-proliferative property of the imidazopyridine derivatives. In the presence of estradiol, X15695 and derivatives outperform the standard of care drug fulvestrant in suppressing the growth of ER+ breast cancer cells, expressing either the wild-type or clinically relevant ER mutant forms (Y537S and D538G) and of patient-derived organoids established from ER+ tumors. Using computational techniques, we discovered that a low pKa value resulting from electron-withdrawing substituents in the 2-phenylimidazo[1,2-a] pyridine compounds is a key feature that identifies them as potent AHR ligands, leading to the potential discovery of additional derivatives for future therapeutic development.
Description:Im Titel steht "(1,2-a)" in eckigen Klammern
Online verfügbar: 29. April 2026, Artikelversion: 17. Mai 2026
Gesehen am 07.07.2026
Description matérielle:Online Resource
ISSN:2589-0042
DOI:10.1016/j.isci.2026.115936

Documents similaires